Next generation probiotics (NGPs), also referred to live biotherapeutic products (LBPs), can target specific diseases and can be used as a revolutionary class of medicines for therapeutic purposes. NGPs are usually derived from next-generation sequencing (NGS) and bioinformatics analysis. With our state-of-the-art technology and industry-leading expertise, Creative Biolabs has developed an unparalleled platform for NGP isolation, identification, and functional characterization. Currently, we have discovered a wide range of potential NGPs, including Akkermansia muciniphila strain, for pre-clinical, clinical, and commercial applications. akkermansia muciniphila psoriasis https://live-biotherapeutic.creative-biolabs.com/akkermansia-muciniphila.htm
Il contenuto caricato verrà spostato in questo album appena creato. Devi crea un account o l se desideri modificare questo album in seguito.